For the treatment of central hypogonadism (i.e., hypogonadotropic hypogonadism), gonadotropic factors (LH and FSH) offer the potential to improve fertility in cases where this aspect is the primary therapeutic aim. This evidence concerns the gene PLOD1 and hypogonadotropic hypogonadism.